Literature DB >> 7540546

Engagement of the osteoclast integrin alpha v beta 3 by osteopontin stimulates phosphatidylinositol 3-hydroxyl kinase activity.

K A Hruska1, F Rolnick, M Huskey, U Alvarez, D Cheresh.   

Abstract

Osteoclast adhesion via integrin alpha v beta 3 to the bone matrix protein osteopontin (OPN) results in stimulation of bone resorption. We characterized an immediate signaling event that takes place upon osteoclast interaction with OPN. OPN binding to alpha v beta 3 results in the rapid production of the phosphoinositides (PtdInsP), including phosphatidylinositol triphosphate (PtdIns 3,4,5P3). Stimulation of 3,4,5-PtdInsP3 production by OPN was produced by increased activity of PtdInsP 3-OH kinase, which was found in immunoprecipitates formed by antibodies to integrin alpha v beta 3. The association of PtdIns 3-OH kinase with integrin may have been through association with c-src. The latter was present in immunoprecipitates formed by the antibodies to integrin alpha v beta 3, and src kinase was activated by OPN. These findings demonstrate a mechanism for rapid generation of cell signals upon matrix protein binding to alpha v beta 3, which resembles the mechanisms used by tyrosine kinase growth factor receptors.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7540546     DOI: 10.1210/endo.136.7.7540546

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  21 in total

1.  rab5 GTPase regulates adenovirus endocytosis.

Authors:  T Rauma; J Tuukkanen; J M Bergelson; G Denning; T Hautala
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

2.  Src kinase activation by direct interaction with the integrin beta cytoplasmic domain.

Authors:  Elena G Arias-Salgado; Sergio Lizano; Sugata Sarkar; Joan S Brugge; Mark H Ginsberg; Sanford J Shattil
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-30       Impact factor: 11.205

3.  An osteopontin-integrin interaction plays a critical role in directing adipogenesis and osteogenesis by mesenchymal stem cells.

Authors:  Qing Chen; Peishun Shou; Liying Zhang; Chunliang Xu; Chunxing Zheng; Yanyan Han; Wenzhao Li; Yin Huang; Xiaoren Zhang; Changshun Shao; Arthur I Roberts; Arnold B Rabson; Guangwen Ren; Yanyun Zhang; Ying Wang; David T Denhardt; Yufang Shi
Journal:  Stem Cells       Date:  2014-02       Impact factor: 6.277

Review 4.  Molecular aspects of osteoclast function.

Authors:  T J Hall; T J Chambers
Journal:  Inflamm Res       Date:  1996-01       Impact factor: 4.575

5.  Alphav integrins mediate adhesion and migration of breast carcinoma cell lines.

Authors:  N C Wong; B M Mueller; C F Barbas; P Ruminski; V Quaranta; E C Lin; J W Smith
Journal:  Clin Exp Metastasis       Date:  1998-01       Impact factor: 5.150

6.  Osteopontin stimulates gelsolin-associated phosphoinositide levels and phosphatidylinositol triphosphate-hydroxyl kinase.

Authors:  M Chellaiah; K Hruska
Journal:  Mol Biol Cell       Date:  1996-05       Impact factor: 4.138

7.  Regulation of sodium-dependent phosphate transport in osteoclasts.

Authors:  A Gupta; X L Guo; U M Alvarez; K A Hruska
Journal:  J Clin Invest       Date:  1997-08-01       Impact factor: 14.808

8.  Overexpression of osteopontin and integrin αv in laryngeal and hypopharyngeal carcinomas associated with differentiation and metastasis.

Authors:  Jian Guang Lu; Yong Li; Liang Li; Xuan Kan
Journal:  J Cancer Res Clin Oncol       Date:  2011-08-19       Impact factor: 4.553

9.  Myosin X regulates sealing zone patterning in osteoclasts through linkage of podosomes and microtubules.

Authors:  Brooke K McMichael; Richard E Cheney; Beth S Lee
Journal:  J Biol Chem       Date:  2010-01-17       Impact factor: 5.157

10.  Extracellular and intracellular mechanisms that mediate the metastatic activity of exogenous osteopontin.

Authors:  Jami Mandelin; Emme C K Lin; Dana D Hu; Susan K Knowles; Kim-Anh Do; Xuemei Wang; E Helene Sage; Jeffrey W Smith; Wadih Arap; Renata Pasqualini
Journal:  Cancer       Date:  2009-04-15       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.